SNDT WOMEN'S UNIVERSITY

BMK Knowledge Resource Centre

Vithaldas Vidyavihar, Juhu Tara Road,
Santacruz (West) Mumbai - 400049

Danshensu Attenuates Diabetes Associated Cognitive Dysfunction by Markedly Reversing Oxidative Stress, Aβ and AChE Activity (Record no. 131230)

MARC details
000 -LEADER
fixed length control field 02079nam a22001337a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250228b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Sunil Shukla
245 ## - TITLE STATEMENT
Title Danshensu Attenuates Diabetes Associated Cognitive Dysfunction by Markedly Reversing Oxidative Stress, Aβ and AChE Activity
300 ## - PHYSICAL DESCRIPTION
Extent pg.503-509
520 ## - SUMMARY, ETC.
Summary, etc. biblio.abstract Background: Evidences suggest that the development of neurodegenerative dementia is accelerated by Diabetes Mellitus (DM), a chronic metabolic condition. In Diabetes Mellitus (DM), improper glucose metabolism produces glycotoxins that cause beta-amyloid peptides to build up and cause oxidative damage to neurons in the brain tissue. Aim: This investigation aims to look at the neuroprotective benefits of Danshensu on memory. Materials and Methods: Involving the behaviour model (Morris water maze) and biochemical activities (measurement of glucose, Aβ(1-42) levels, AChE, MDA, and GSH) for acute as well as chronic conditions in STZ-induced diabetic rats at 2 doses of Danshensu namely 2 mg/kg and 5 mg/kg body weight per day. Results: Results demonstrated an improvement in learning ability in both acute and chronic level treatment. Additionally, there was an alteration in the levels of biochemical markers after treatment with Danshensu, indicating that this substance may influence transmission of cholinergic neurons and potentially alleviate cognitive impairments brought on by oxidative damage. Conclusion: Danshensu ameliorates the effects of STZ more effectively at a dose of 5 mg/kg rather than 2 mg/kg at the acute level of treatment whereas at a chronic level, both 2 mg/kg and 5 mg/kg doses demonstrate an equally significant result. Therefore, Danshensu is a potential candidate for treating hyperglycemia-induced cognitive dysfunction.
654 ## - SUBJECT ADDED ENTRY--FACETED TOPICAL TERMS
Subject <a href="Diabetes, ">Diabetes, </a>
-- <a href=" Alzheimer’s disease, "> Alzheimer’s disease, </a>
-- <a href="Oxidative stress, ">Oxidative stress, </a>
-- <a href=" Danshensu, "> Danshensu, </a>
-- <a href=", Beta-amyloid, ">, Beta-amyloid, </a>
-- <a href=" AChE activity."> AChE activity.</a>
773 0# - HOST ITEM ENTRY
Host Biblionumber 125266
Host Itemnumber 109790
Place, publisher, and date of publication Banglore Association of Pharmaceutical Tearchers of India
Title Indian Journal of Pharmaceutical Education and Research
International Standard Serial Number 0019-5464
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Location (home branch) Sublocation or collection (holding branch) Date acquired Koha issues (times borrowed) Piece designation (barcode) Koha date last seen Price effective from Koha item type
    Dewey Decimal Classification     SNDT Juhu SNDT Juhu 28/02/2025   jp225.18 28/02/2025 28/02/2025 Journal Article